It has been reported that suppression of the renin-angiotensin system (RAS) by angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin II type 1 receptor blockers (ARBs) provides an effective treatment against cardiovascular diseases such as hypertension and cardiac failure [1, 2]. This evidence concerns the gene ACE and heart failure.